NVNO

10.13

0.25% -0.025

Dopo l'orario di chiusura: 10.33 0.20 +1.97%

Envveno Medical Corporation (NVNO)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$10.15

Aprire:

$9.9564

Volume 24 ore:

6,180

Relative Volume:

0.30

Capitalizzazione di mercato:

$6.64M

Reddito:

Utile/perdita netta:

$-19.47M

Rapporto P/E:

-0.3969

EPS:

-25.5243

Flusso di cassa netto:

$-15.57M

1 W Prestazione:

-4.97%

1M Prestazione:

+1.30%

6M Prestazione:

-68.06%

1 anno Prestazione:

-89.00%

Intervallo 1D:

$9.79

$10.43

Intervallo di 1 settimana:

$9.79

$11.53

Portata 52W:

$8.67

$196.70

Envveno Medical Corporation Stock (NVNO) Company Profile

Nome

Envveno Medical Corporation

Settore

Healthcare (1114)

Industria

Medical Devices (143)

Telefono

949-261-2900

Indirizzo

70 DOPPLER, IRVINE

Dipendente

Cinguettio

Prossima data di guadagno

2026-03-26

Ultimi documenti SEC

NVNO's Discussions on Twitter

Compare NVNO vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NVNO Envveno Medical Corporation	10.13	6.66M	0	-19.47M	-15.57M	-25.52
ABT Abbott Laboratories	102.67	177.03B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	328.59	124.89B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	86.65	110.08B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	62.75	93.53B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	80.08	45.84B	6.07B	1.06B	1.34B	1.8063

Envveno Medical Corporation Borsa (NVNO) Ultime notizie

Mar 30, 2026

enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - The News-Star

Mar 30, 2026

Mar 28, 2026

enVVeno Medical Corp (NVNO) SEC filings - GuruFocus

Mar 28, 2026

enVVeno Medical Corp (NVNO) Stock Earnings Transcripts - GuruFocus

Mar 28, 2026

enVVeno Medical Reports FY GAAP EPS of -$33.06 Amid Reverse Stock Split - Intellectia AI

Mar 28, 2026

Mar 27, 2026

enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - Coldwater Daily Reporter

Mar 27, 2026

Market Pulse: Whats the MACD signal for enVVeno Medical Corporation2026 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn

Mar 27, 2026

AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO) - TipRanks

Mar 27, 2026

enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year - TipRanks

Mar 27, 2026

No replacement vein valves are approved. enVVeno is pushing one toward a 2026 trial - Stock Titan

Mar 27, 2026

Mar 26, 2026

[10-K] enVVeno Medical Corp Files Annual Report - Stock Titan

Mar 26, 2026

enVVeno Medical 10-K: Net loss $19.5M, no revenue, EPS not disclosed - TradingView

Mar 26, 2026

Insider Sell: Francis Duhay Sells Shares of enVVeno Medical Corp (NVNO) - GuruFocus

Mar 13, 2026

Director at enVVeno Medical (NVNO) sells 140 shares under Rule 10b5-1 plan - Stock Titan

Mar 13, 2026

Mar 12, 2026

[144] enVVeno Medical Corp SEC Filing - Stock Titan

Mar 12, 2026

Mar 11, 2026

Volatility Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn

Mar 11, 2026

Mar 09, 2026

enVVeno Medical (NVNO) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 09, 2026

Mar 04, 2026

NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times

Mar 04, 2026

Mar 02, 2026

Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World

Mar 02, 2026

Mar 01, 2026

NVNO SEC FilingsEnvveno Medical Corporation 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 01, 2026

Feb 24, 2026

NVNO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026

Can enVVeno Medical Corporation maintain sales growthQuarterly Profit Summary & Daily Growth Stock Tips - baoquankhu1.vn

Feb 24, 2026

Feb 20, 2026

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Feb 20, 2026

enVVeno Medical (NVNO) investor urges halt to trials, strategic review - Stock Titan

Feb 20, 2026

Feb 18, 2026

enVVeno Medical Announces Reverse Stock Split - Press & Sun-Bulletin

Feb 18, 2026

Feb 17, 2026

Perceptive funds hold 2.05M enVVeno (NVNO) shares and warrants - Stock Titan

Feb 17, 2026

Feb 15, 2026

NVNO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Feb 15, 2026

Envveno Medical Corporation Azioni (NVNO) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

ZBH

$90.42

2.03%

STE

$221.13

0.80%

DXCM

$62.80

1.45%

PHG

$27.40

3.28%

GEHC

$71.18

3.50%

$80.08

0.73%

Envveno Medical Corporation (NVNO)

Envveno Medical Corporation Stock (NVNO) Company Profile

Compare NVNO vs ABT, SYK, MDT, BSX, EW

Envveno Medical Corporation Borsa (NVNO) Ultime notizie

enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement - The News-Star

enVVeno Medical Corp (NVNO) SEC filings - GuruFocus

enVVeno Medical Corp (NVNO) Stock Earnings Transcripts - GuruFocus

enVVeno Medical Reports FY GAAP EPS of -$33.06 Amid Reverse Stock Split - Intellectia AI

enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System - Coldwater Daily Reporter

Market Pulse: Whats the MACD signal for enVVeno Medical Corporation2026 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn

AI Models Reiterate High-Risk, Speculative View on enVVeno Medical (NVNO) - TipRanks

enVVeno Medical reports FY25 EPS ($33.06) vs. ($44.53) last year - TipRanks

No replacement vein valves are approved. enVVeno is pushing one toward a 2026 trial - Stock Titan

[10-K] enVVeno Medical Corp Files Annual Report - Stock Titan

enVVeno Medical 10-K: Net loss $19.5M, no revenue, EPS not disclosed - TradingView

5HJ0 Stock Price and Chart — FWB:5HJ0 - TradingView

If You Invested $1,000 in Envveno Medical Corporation (NVNO) - Stock Titan

NVNO's Shares Decline on Unfavorable FDA Review Outcome for VenoValve - MSN

Insider Sell: Francis Duhay Sells Shares of enVVeno Medical Corp (NVNO) - GuruFocus

Director at enVVeno Medical (NVNO) sells 140 shares under Rule 10b5-1 plan - Stock Titan

[144] enVVeno Medical Corp SEC Filing - Stock Titan

Volatility Watch: Is enVVeno Medical Corporation a strong candidate for buy and hold2026 Spike Watch & Safe Capital Preservation Plans - baoquankhu1.vn

enVVeno Medical (NVNO) Stock Analysis Report | Financials & Insights - Benzinga Japan

NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives - The Manila Times

Reviewing Pressure BioSciences (OTCMKTS:PBIO) & enVVeno Medical (NASDAQ:NVNO) - Defense World

NVNO SEC FilingsEnvveno Medical Corporation 10-K, 10-Q, 8-K Forms - Stock Titan

NVNO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Can enVVeno Medical Corporation maintain sales growthQuarterly Profit Summary & Daily Growth Stock Tips - baoquankhu1.vn

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

enVVeno Medical (NVNO) investor urges halt to trials, strategic review - Stock Titan

enVVeno Medical Announces Reverse Stock Split - Press & Sun-Bulletin

Perceptive funds hold 2.05M enVVeno (NVNO) shares and warrants - Stock Titan

NVNO Earning Date, Earning Analysis and Earning Prediction - Intellectia AI

Envveno Medical Corporation Azioni (NVNO) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a NVNO